Edition:
United States

X T L Biopharmaceuticals Ltd (XTLB.OQ)

XTLB.OQ on NASDAQ Stock Exchange Capital Market

1.81USD
17 Jul 2018
Change (% chg)

$-0.03 (-1.63%)
Prev Close
$1.84
Open
$1.85
Day's High
$1.85
Day's Low
$1.80
Volume
2,100
Avg. Vol
9,457
52-wk High
$3.91
52-wk Low
$1.58

Chart for

About

XTL Biopharmaceuticals Ltd. is a biopharmaceutical company. The Company focuses on the acquisition and development of pharmaceutical drugs for the treatment of medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action,... (more)
No analyst recommendations are available for .

Overall

Beta: 0.12
Market Cap(Mil.): $9.33
Shares Outstanding(Mil.): 5.14
Dividend: --
Yield (%): --

Financials

  XTLB.OQ Industry Sector
P/E (TTM): 8.66 214.90 33.15
EPS (TTM): 0.21 -- --
ROI: 15.93 -3.85 13.23
ROE: 22.08 -5.38 15.27

Earnings vs. Estimates